 "pharma")
Ajanta Pharma on Friday posted 15 per cent rise in consolidated net profit at Rs 196 crore for the second quarter ended September 30, 2021.
The company had reported a net profit of Rs 170 crore in July-September period a year ago.
Revenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
The drug maker said its domestic sales were up 23 per cent during the period under review at Rs 248 crore as compared with Rs 202 crore in the corresponding period of the previous fiscal year.
Exports were at Rs 611 crore during the period, up 22 per cent from Rs 499 crore in the year-ago period.
Also Read
The company noted that its board has approved an interim dividend of Rs 9.5 (475 per cent) per equity share of face value of Rs 2 per share for 2021-22.
The interim dividend will be paid on or after November 16, 2021, it added.
Shares of the company were trading 1.17 per cent down at Rs 2,102.80 apiece on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
